AU2002350975A1 - Diagnosis of inflammatory bowel disease - Google Patents

Diagnosis of inflammatory bowel disease

Info

Publication number
AU2002350975A1
AU2002350975A1 AU2002350975A AU2002350975A AU2002350975A1 AU 2002350975 A1 AU2002350975 A1 AU 2002350975A1 AU 2002350975 A AU2002350975 A AU 2002350975A AU 2002350975 A AU2002350975 A AU 2002350975A AU 2002350975 A1 AU2002350975 A1 AU 2002350975A1
Authority
AU
Australia
Prior art keywords
diagnosis
inflammatory bowel
bowel disease
disease
inflammatory
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002350975A
Other versions
AU2002350975A8 (en
Inventor
Maxine Johanna Allen
John Matthew Herbert
David Van Heel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oxagen Ltd
Original Assignee
Oxagen Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oxagen Ltd filed Critical Oxagen Ltd
Publication of AU2002350975A8 publication Critical patent/AU2002350975A8/en
Publication of AU2002350975A1 publication Critical patent/AU2002350975A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/06—Gastro-intestinal diseases
    • G01N2800/065—Bowel diseases, e.g. Crohn, ulcerative colitis, IBS

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU2002350975A 2001-12-17 2002-12-17 Diagnosis of inflammatory bowel disease Abandoned AU2002350975A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0130116.7 2001-12-17
GBGB0130116.7A GB0130116D0 (en) 2001-12-17 2001-12-17 Gene linkage
PCT/GB2002/005719 WO2003052412A2 (en) 2001-12-17 2002-12-17 Diagnosis of inflammatory bowel disease

Publications (2)

Publication Number Publication Date
AU2002350975A8 AU2002350975A8 (en) 2003-06-30
AU2002350975A1 true AU2002350975A1 (en) 2003-06-30

Family

ID=9927755

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002350975A Abandoned AU2002350975A1 (en) 2001-12-17 2002-12-17 Diagnosis of inflammatory bowel disease

Country Status (3)

Country Link
AU (1) AU2002350975A1 (en)
GB (1) GB0130116D0 (en)
WO (1) WO2003052412A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3094973B1 (en) 2013-11-07 2020-07-29 Diagnodus Limited Biomarkers

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1288499A (en) * 1997-10-31 1999-05-24 Cedars-Sinai Medical Center Methods of identifying and diagnosing inflammatory bowel disease or subtypes with the nramp locus

Also Published As

Publication number Publication date
WO2003052412A2 (en) 2003-06-26
GB0130116D0 (en) 2002-02-06
WO2003052412A3 (en) 2004-02-26
AU2002350975A8 (en) 2003-06-30

Similar Documents

Publication Publication Date Title
EP1581119A4 (en) Compositions and methods for the therapy and diagnosis of inflammatory bowel disease
HUP0303622A3 (en) Emedies for inflammatory bowel diseases
WO2003034984A9 (en) Compositions and methods for the diagnosis and treatment of inflammatory bowel disorders
AU6408901A (en) Early diagnosis of conformational diseases
AU2001289617A1 (en) Diagnosis of diseases associated with signal transduction
AU2003224414A1 (en) Acoustic diagnosis of sinusitis
AU2001227815A1 (en) Chemically specific imaging of tissue
EP1592384A3 (en) Cop 1 for treatment of inflammatory bowel diseases
AU2446801A (en) Treatment for inflammatory bowel disease (ibd) and related conditions
EP1720444A4 (en) Vaginal speculum assembly
AU2002308315A1 (en) Diagnosis of physiological conditions by proteomic characterization
EP1424931A4 (en) Early diagnosis of stroke
GB0124315D0 (en) Inflammatory bowel disease
AU2003282878A1 (en) Diagnosis of invasive mold infection
AU2002350975A1 (en) Diagnosis of inflammatory bowel disease
AU4962001A (en) Diagnosis of autoimmune disease
AU2002337831A1 (en) Methods of diagnosis of autoimmune disease
AU2001253024A1 (en) Diagnosis and treatment of gastrointestinal disease
AU2002952084A0 (en) Treatment of inflammatory bowel disease
AU2002240410A1 (en) Methods for treatment of inflammatory bowel disease
AU2003902452A0 (en) Treatment of inflammatory bowel disease
AUPQ048799A0 (en) Diagnosis of cardiovascular disease
AU2003272675A1 (en) Use of estrogen receptor ligands for the treatment of inflammatory bowel disease
AU2001292306A1 (en) Remedies for inflammatory bowel diseases
AU2003234488A1 (en) Diagnosis of glaucoma

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase